Pharmaceutical Lactose System MINS-002

£12.00

Pharmaceutical Lactose System MINS-002 is a high-purity pharmaceutical-grade lactose solution engineered as a reliable excipient for tablet compression, capsule filling, and advanced drug formulation applications. It delivers excellent flowability, compressibility, and consistency to support efficient pharmaceutical manufacturing processes. With stringent quality control, global supply capability, and compliance-focused production standards, it provides manufacturers with a dependable ingredient for high-performance medication development.

Description

Product Overview

Pharmaceutical Lactose System MINS-002 is a high-purity pharmaceutical-grade lactose excipient designed for use in the formulation and manufacturing of oral solid dosage forms, including tablets, capsules, and dry powder inhalation products. It provides excellent compressibility, flowability, and blending performance, enabling efficient pharmaceutical production with consistent dosage accuracy. As a critical functional excipient, this product supports global pharmaceutical manufacturers in achieving reliable formulation performance, regulatory compliance, and scalable production efficiency. Its strategic importance lies in meeting the growing demand for safe, high-quality excipients across the expanding global healthcare and pharmaceutical markets.

Key Specifications & Technical Characteristics

  • Chemical Composition / Material Components:
    • Lactose monohydrate or anhydrous lactose (pharmaceutical-grade milk sugar derivative)
    • Natural disaccharide composed of glucose and galactose units
  • Purity Level / Grade:
    • Pharmaceutical Grade (USP/NF, EP, BP compliant options available)
    • High purity suitable for regulated pharmaceutical applications
    • Low microbial load with controlled impurity profile
  • Physical Characteristics:
    • Form: Fine powder or granulated crystalline particles
    • Color: White to off-white
    • Odor: Neutral, characteristic of pharmaceutical lactose
    • Particle Size: Available in controlled ranges suitable for direct compression, wet granulation, and inhalation applications
    • Flowability: Excellent powder flow characteristics for automated processing
    • Density: Controlled bulk density for optimized formulation performance
  • Packaging Options:
    • 25 kg multi-layer paper bags with polyethylene liner
    • 500 kg–1,000 kg bulk bags (FIBC) for industrial-scale production
    • Customized packaging available based on customer requirements
  • Shelf Life:
    • Typically 24–36 months when stored in dry, cool conditions away from moisture contamination

Core Industrial Applications

  • Pharmaceutical Manufacturing:
    • Used as a filler, diluent, and carrier in tablet and capsule formulations
    • Supports direct compression and granulation processes for efficient production
  • Dry Powder Inhaler (DPI) Production:
    • Functions as a carrier particle to improve active pharmaceutical ingredient dispersion and inhalation performance
  • Nutraceutical Industry:
    • Used in premium supplement formulations requiring pharmaceutical-grade excipient quality
  • Research & Contract Manufacturing Organizations (CMOs):
    • Provides reliable excipient performance for formulation development and commercial-scale manufacturing

Performance Advantages:

  • Superior compressibility improves tablet hardness and manufacturing efficiency
  • Consistent particle size distribution enhances blending uniformity and dosage accuracy
  • High purity reduces formulation risks and supports regulatory compliance
  • Stable supply performance helps manufacturers maintain uninterrupted production schedules

Competitive Advantages

  • Quality Consistency: Manufactured under strict quality control systems with batch-to-batch consistency and comprehensive analytical testing.
  • Supply Reliability: Supported by established pharmaceutical raw material supply networks to ensure dependable global availability.
  • Logistics Capability: Suitable for bulk international shipments with flexible packaging solutions and container-scale delivery options.
  • Price Competitiveness: Provides cost-efficient sourcing advantages while maintaining pharmaceutical-grade performance standards.
  • Sustainability Benefits: Derived from renewable dairy-based resources with efficient processing and responsible manufacturing practices.
  • Technical Support & Documentation: Available with Certificates of Analysis (COA), Safety Data Sheets (SDS), regulatory documentation, and quality compliance support for pharmaceutical buyers.

Commercial & Supply Information

  • Minimum Order Quantity (MOQ): BULK 20MT
  • Loading Capacity: Approximately 20–25 MT per 20-foot container (subject to packaging configuration and shipping requirements)

Additional information

Price

per kg

Reviews

There are no reviews yet.

Be the first to review “Pharmaceutical Lactose System MINS-002”

Your email address will not be published. Required fields are marked *

Add to cart